Coimbra Health School
Coimbra, 3046-854, Portugal
NCT Number: NCT05866848
The goal of this clinical trial is to evaluate in clinically healthy young people if:
* after caffeine ingestion, there are variations in blood velocity of the middle cerebral arteries (VMCA), * this variation is dependent on the administered dose.
Transcranial Doppler ultrasonography was used to record blood VMCA in three groups of 15 clinically healthy young adults each - no caffeine, low caffeine (45 mg) and high caffeine group (120 mg). Transcranial Doppler ultrasonography provided simultaneous bilateral VMCA measurements while subjects performed functional tests (hyperventilation and hypoventilation orders) and three cognitive activities (Test 1, short-term remembering, Test 2, solving a vocabulary problem, and Test 3, solving a math problem) each in 31-second tests with 1-minute rest between them. Participants were assessed before and 30 minutes after caffeine ingestion.
Looking for future studies?
Notify Me18 year–30 year
All sexes
Interventional
Not applicable
Coimbra, 3046-854, Portugal
Were used in the study, Capsules dosed with 45mg and 120 mg of anhydrous caffeine and flour capsules as a placebo. In the preparation of the capsules, a semi-automatic capsulator No. 0 (Capsunorm® by Tecnyfarma®) were used, colorless hard gelatin capsules No. 0 by Acopharma® and anhydrous caffeine (Biochem®, C.A.S. 58-08-2).
Viasys Sonara transcranial Doppler unit and a 2 MHz probe were used to sample the middle cerebral artery at depths of 60 millimeters, using emission doppler pulsed performing spectral analysis in real time. Two probes (bilaterally) of 2MHz were placed at a depth between 55 and 60 mm, thus making it possible to analyse both middle cerebral arteries simultaneously.
Each participant was asked not to ingest caffeine and exercise vigorously for at least 12 hours before the assessment. In the case of smokers, they were also asked not to smoke for at least 2 hours before the evaluation. The laboratory had medium luminosity, silent and controlled temperature (23º/24ºC). To avoid inter-observer errors, all examinations were performed by the same investigator who was not aware of what dose was/had been administered to the participant.
Subjects were tested while seated in a reclining chair located in a dimly lit, sound-attenuated room and performed the activities with their eyes closed.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Flour capsules as a placebo.
Capsules dosed with 45mg of anhydrous caffeine.
Capsules dosed with 120mg of anhydrous caffeine.
Time frame: 30 minutes
Changes in Mean Velocity, measure in m/s from baseline to 30 minutes after caffeine ingestion.
Time frame: 30 minutes
By performing Hypoventilation, changes in Mean Velocity, measure in m/s from baseline to 30 minutes after caffeine ingestion.
Time frame: 30 minutes
By performing Hyperventilation, changes in Mean Velocity, measure in m/s from baseline to 30 minutes after caffeine ingestion.
Time frame: 30 minutes
With short-term memory test, changes in Mean Velocity, measure in m/s from baseline to 30 minutes after caffeine ingestion.
Time frame: 30 minutes
With solving vocabulary problems, changes in Mean Velocity, measure in m/s from baseline to 30 minutes after caffeine ingestion.
Time frame: 30 minutes
With solving math problems, changes in Mean Velocity, measure in m/s from baseline to 30 minutes after caffeine ingestion.
Time frame: 30 minutes
Changes in Mean Velocity, measure in m/s from baseline to 30 minutes after caffeine ingestion.
Time frame: 30 minutes
By performing Hypoventilation, changes in Peak systolic velocity, measure in m/s from baseline to 30 minutes after caffeine ingestion.
Time frame: 30 minutes
By performing Hyperventilation, changes in Peak systolic velocity, measure in m/s from baseline to 30 minutes after caffeine ingestion.
Time frame: 30 minutes
With short-term memory test, changes in Peak systolic velocity, measure in m/s from baseline to 30 minutes after caffeine ingestion.
Time frame: 30 minutes
With solving vocabulary problems, changes in Peak systolic velocity, measure in m/s from baseline to 30 minutes after caffeine ingestion.
Time frame: 30 minutes
With solving math problems, changes in Peak systolic velocity, measure in m/s from baseline to 30 minutes after caffeine ingestion.
Time frame: 30 minutes
Changes in Mean Velocity, measure in m/s from baseline to 30 minutes after caffeine ingestion.
Time frame: 30 minutes
By performing Hypoventilation, changes in Vend-diastolic velocity, measure in m/s from baseline to 30 minutes after caffeine ingestion.
Time frame: 30 minutes
By performing Hyperventilation, changes in Vend-diastolic velocity, measure in m/s from baseline to 30 minutes after caffeine ingestion.
Time frame: 30 minutes
With short-term memory test, changes in Vend-diastolic velocity, measure in m/s from baseline to 30 minutes after caffeine ingestion.
Time frame: 30 minutes
With solving vocabulary problems, changes in Vend-diastolic velocity, measure in m/s from baseline to 30 minutes after caffeine ingestion.
Time frame: 30 minutes
With solving math problems, changes in Vend-diastolic velocity, measure in m/s from baseline to 30 minutes after caffeine ingestion.
Time frame: 30 minutes
Changes in Heart Rate, measure in bpm from baseline to 30 minutes after caffeine ingestion.
Time frame: 30 minutes
By performing Hypoventilation, changes in Heart Rate, measure in bpm from baseline to 30 minutes after caffeine ingestion.
Time frame: 30 minutes
By performing Hyperventilation, changes in Heart Rate, measure in bpm from baseline to 30 minutes after caffeine ingestion.
Time frame: 30 minutes
With short-term memory test, changes in Heart Rate, measure in bpm from baseline to 30 minutes after caffeine ingestion.
Time frame: 30 minutes
With solving vocabulary problems, changes in Heart Rate, measure in bpm from baseline to 30 minutes after caffeine ingestion.
Time frame: 30 minutes
With solving math problems, changes in Heart Rate, measure in bpm from baseline to 30 minutes after caffeine ingestion.
Escola Superior de Tecnologia da Saúde de Coimbra
Other
Effects of Caffeine on Cerebral Blood Flow in Clinically Healthy Young People
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05727332
Cardiovascular System
University, Mississippi, United States
View Trial DetailsNCT02979327
Cardiovascular System, Hemodynamics
Rochester, Minnesota, United States
View Trial DetailsNCT04209738
Cardiovascular System, Chronic Disease
Filderstadt, Baden-Wurttemberg, Germany
View Trial DetailsNCT05289817
Autonomic Nervous System, Cardiovascular System
A Coruña, Spain
View Trial Details